Scoutby Fusion42
Open Bay Island Cell in the live Scout dashboard →

Explore: Biotech · Series A · China

Bay Island Cell

🇨🇳Shenzhen, China

Series A

Cell therapy biotech company developing non-gene-editing universal CAR-T platform founded by former Legend Biotech executive Fan Xiaohu. Bay Island Cell is a healthtech and deeptech startup based in Shenzhen, China, founded 2020, at Series A stage, with $19.6M raised to date.

Bay Island Cell is tracked live on Scout, Fusion42's database of newly funded startups, where founders watch who is raising, who is backing whom, and where their market is moving.

Sectors

healthtechdeeptechbiotechcell-therapy

Geographies

China

Total raised

$19.6M

Founded

2020

Model

transactional

Investors

null

Visit website

🔒 Valuation & traction

Sign in to view

🔒 Full round history

Sign in to view

Sign in to see Bay Island Cell's full profile

Valuation signals, web traffic, full round history and team. Free account, Google sign-in.

Create free account

Frequently asked questions

What does Bay Island Cell do?
Cell therapy biotech company developing non-gene-editing universal CAR-T platform founded by former Legend Biotech executive Fan Xiaohu.
Where is Bay Island Cell based?
Bay Island Cell is based in Shenzhen, China, founded in 2020.
How much has Bay Island Cell raised?
Bay Island Cell has raised $19.6M in tracked funding and is currently at the series-a stage.
Who has invested in Bay Island Cell?
Investors in Bay Island Cell include null.